Search results
1 heavyweight FTSE 100 share I’d buy as London retakes its crown
Fool.co.uk via Yahoo Finance UK· 6 days agoSome Footsie firms are extremely large, but that doesn't mean they couldn't get even bigger. Here's...
FTSE 100 Live 19 June: UK inflation hits Bank of England's 2% target, blue-chips slightly lower
Evening Standard via Yahoo Finance UK· 7 days agoThe UK’s inflation rate today slowed to 2%, its lowest level in almost three years. Despite the...
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
Reuters· 1 day ago, opens new tab to a lawsuit accusing them of illegally helping to fund terrorism that killed or...
I just put £4k into my SIPP. Here’s where I’m going to invest it
Fool.co.uk via Yahoo Finance UK· 4 days agoEdward Sheldon's been contributing to his SIPP to build wealth for retirement. Here’s a look at...
‘I’ve saved £44,000 – can I retire as a millionaire at 60?’
Daily Telegraph· 6 days agoCollective investments simplify things by providing built-in diversification and can save you the...
LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake
Morningstar· 18 hours ago"One question that everyone asks is whether last week's good news marked the finale of the Nvidia's surge to the top, and if the past three-day selloff is the beginning of a sharper downside ...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
Daily Telegraph· 1 day agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Finance UK· 7 days agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...
1 heavyweight FTSE 100 share I'd buy as London retakes its crown
Motley Fool UK· 6 days agoSome Footsie firms are extremely large, but that doesn't mean they couldn't get even bigger. Here's...
Small-Molecule Price Controls Are Short-Sighted
Forbes· 2 days agoThe combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over the...